Psychiatric NP Scope of Practice for Anxiety in Georgia

If you’re a psychiatrist or PMHNP treating anxiety disorders via telehealth, you’re navigating one of the most complex regulatory landscapes in mental health. Between federal DEA rules, state-by-state prescribing laws, and shifting telehealth policies, it’s easy to feel like compliance is a moving target.

Here’s the reality: you can legally treat anxiety patients and prescribe medications via telehealth right now — including controlled substances like benzodiazepines — but the rules vary dramatically depending on where your patient is located and what credentials you hold. This guide breaks down exactly what you need to know to practice legally and confidently across state lines.

The Federal Baseline: DEA Rules for Telehealth Prescribing

Let’s start with the big one: can you prescribe benzodiazepines via telehealth for a new anxiety patient you’ve never seen in person?

As of February 2026, the answer is yes — but only because federal authorities extended COVID-era flexibilities through December 31, 2025 (and likely beyond). The DEA announced its third extension of telemedicine prescribing rules in late 2024, allowing DEA-registered practitioners to prescribe Schedule II–V controlled substances via telemedicine without a prior in-person exam.

Why this matters for anxiety treatment: Many first-line anxiety medications (SSRIs, SNRIs, buspirone) aren’t controlled substances, so they’ve never been restricted by federal telehealth rules. The regulatory challenge is with benzodiazepines — alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin) — which are Schedule IV controlled substances. Before COVID, the Ryan Haight Act generally required an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’

The temporary waivers lifted that requirement. You can evaluate a panic disorder patient via video, determine that alprazolam is clinically appropriate, and e-prescribe it — all without arranging an in-person visit first.

The uncertainty: In early 2023, the DEA proposed new rules that would have reinstated in-person visit requirements (with limited exceptions for a 30-day supply). After receiving over 38,000 public comments — many from mental health providers warning about access disruptions — the DEA postponed implementation and is working on what it calls ‘a new path forward for telemedicine.’

What this means for your practice: Federal telehealth prescribing flexibility remains in place through at least the end of 2025, possibly longer. But you should monitor DEA announcements and have a contingency plan. Some platforms are already preparing for potential hybrid models — like partnering with local clinics where patients could get an in-person exam if new rules require it.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs. PMHNPs: Different Scope, Different Rules

For Psychiatrists (MD/DO)

Your scope of practice is straightforward: you have full independent authority to diagnose and treat anxiety disorders in every state. No supervision, no collaborative agreements, no formulary restrictions. You can prescribe any anxiolytic medication — from propranolol for performance anxiety to benzodiazepines for panic disorder — as long as you comply with federal and state prescribing laws.

Your regulatory hurdles are administrative, not scope-based:

• Multi-state licensure: You must hold a valid medical license in each state where your patients are located. Practicing across state lines without proper licensure is illegal, even via telehealth. The Interstate Medical Licensure Compact (IMLC) can help — Texas, Illinois, Pennsylvania, and Florida are member states. California and New York are not, so you’ll go through conventional licensing there.

• DEA registration: You need a DEA number in the state where you’re practicing (typically your primary practice location for telehealth).

• State PDMP compliance: Almost every state requires checking the Prescription Drug Monitoring Program before prescribing controlled substances. For example, New York mandates PDMP checks for every Schedule II–IV prescription. Pennsylvania requires checking before each benzodiazepine or opioid prescription. Florida requires checks before any controlled prescription and every 90 days thereafter.

• E-prescribing: Most states mandate electronic prescribing for controlled substances. New York and California require e-prescribing for all medications. Your telehealth platform should provide EPCS-compliant e-prescribing with two-factor authentication.

For PMHNPs (Psychiatric Nurse Practitioners)

You can assess, diagnose, and treat anxiety disorders in all 50 states, but state laws vary dramatically on practice independence and prescribing limits.

Full Practice Authority States (for anxiety treatment):

• Illinois: Experienced NPs (4,000+ hours) can practice independently, including prescribing Schedule II–V controlled substances. For Schedule II opioids only, a physician consultation relationship is required for the first 5 years of full practice authority. Benzodiazepines? No physician consultation needed.
• New York: NPs with 3,600+ hours of practice can work independently without collaborative agreements (made permanent in 2022).
• California: Transitioning to independence. As of 2023, experienced NPs can practice independently in certain settings. By 2026, qualified NPs will have full independence across all settings.

Restricted Practice States (physician collaboration required):

• Texas: NPs must have a Prescriptive Authority Agreement with a physician. One major limitation: Texas APRNs cannot prescribe Schedule II controlled substances in outpatient settings (except in hospitals, emergency departments, or hospice). This mainly affects ADHD stimulants, not typical anxiety meds (which are Schedule IV).
• Florida: Psychiatric NPs must practice under a physician supervisory protocol. However, Florida has a specific exemption for ‘psychiatric nurses’: while general NPs are limited to 7-day supplies of Schedule II drugs, psychiatric-certified NPs treating mental illness can prescribe Schedule II psychiatric medications without the 7-day limit.
• Pennsylvania: Collaborative agreement required. NPs can prescribe Schedule II for up to 30 days, Schedule III–IV for up to 90 days. The collaborating physician must approve controlled substance prescribing in the agreement.

Practical impact: If you’re a PMHNP joining a telehealth platform like Klarity, the platform’s infrastructure must adapt to each state’s rules. In restrictive states, they’ll ensure physician collaborators are available. In full practice states, you can operate independently.

State-Specific Telehealth Prescribing Rules That Actually Matter

Beyond scope of practice, each state has unique telehealth and prescribing regulations. Here’s what you need to know for the major markets:

California

• No in-person exam required for telehealth prescribing if standard of care is met. Even asynchronous methods (structured questionnaires) can be part of the evaluation.
• No state restrictions on controlled substance prescribing via telehealth beyond federal law.
• CURES PDMP: Must check for Schedule II–IV drugs at initial prescription and at least every 4 months.
• E-prescribing mandatory for all prescriptions (since 2022).
• Licensure: Must have full California medical license (not in IMLC). No special telehealth license available.

Texas

• Synchronous audio-visual exam required to establish the patient relationship for new patients.
• Can prescribe controlled substances via telehealth except for chronic pain management with Schedule II drugs (doesn’t affect anxiety treatment).
• PDMP mandatory for opioids, benzodiazepines, barbiturates, and carisoprodol before prescribing.
• For NPs: Cannot prescribe Schedule II outside hospital/hospice settings, must have physician prescriptive delegation agreement.
• Licensure: Texas joined IMLC in 2021 (easier for out-of-state MDs to get licensed).

Florida

• Explicit telehealth law with controlled substance carve-outs: Schedule II prescribing via telehealth is banned except for psychiatric treatment, inpatient care, hospice, or nursing homes. This means you can prescribe Schedule II stimulants for ADHD/anxiety via telehealth as a psychiatric provider.
• Patient consent required for telehealth services (must be documented).
• E-FORCSE PDMP: Check required before any controlled prescription and every 90 days.
• Out-of-state providers: Florida offers Telehealth Provider Registration — out-of-state clinicians can register to treat Florida patients without getting a full FL license (unique among states).
• E-prescribing mandatory for controlled substances.

New York

• No in-person exam requirement — telehealth is acceptable for establishing care if standard of care is met.
• I-STOP PDMP: Must check for every Schedule II, III, or IV prescription (including all benzodiazepines).
• E-prescribing mandatory for all medications (since 2016).
• For NPs: Experienced NPs (3,600+ hours) practice independently; newer NPs need collaborative agreements until they hit the hour threshold.
• Licensure: Not in IMLC; must obtain full NY medical license.

Pennsylvania

• No state-mandated in-person exam for telehealth prescribing (follows federal rules).
• PDMP required before each prescription of opioids or benzodiazepines (interpreted as every refill).
• E-prescribing mandatory for controlled substances (since 2019).
• For NPs: Collaborative agreement required; Schedule II limited to 30-day supply, Schedule III–IV to 90-day supply.
• Licensure: PA joined IMLC in 2017 (streamlined for out-of-state MDs).

Illinois

• No in-person exam required by state law; telehealth permitted for evaluations if standard of care met.
• Audio-only telehealth explicitly allowed for mental health services (made permanent in 2021).
• PDMP registration required; must check for Schedule II prescriptions (encouraged for all controlled substances).
• State controlled substance license required in addition to DEA registration.
• For NPs: Full practice authority available after 4,000 hours + training. Physician consult required for Schedule II opioids (not benzodiazepines) during first 5 years of FPA.
• Licensure: IL joined IMLC in 2018 for physicians; entered Nurse Licensure Compact in 2022 for RNs.

What This Means for Your Practice Economics

Understanding these regulations isn’t just about compliance — it’s about where you can actually build a sustainable anxiety treatment practice.

The multi-state licensing challenge: If you want to see patients across multiple states, you’re looking at significant upfront investment. Medical licenses typically cost $500–$1,500 per state, plus application time, credential verification, and ongoing renewal fees. IMLC can help for physicians in member states, but you’ll still pay individual state fees.

For solo practitioners, this creates a chicken-and-egg problem: you need licenses to see patients in a state, but you need patient volume to justify the licensing cost. Many providers start with 1–2 high-volume states (California, Texas, Florida, New York together represent ~30% of the US population) and expand as demand grows.

For platforms like Klarity Health, the value proposition is clear: they handle the patient acquisition across states, so you’re guaranteed volume to justify multi-state licensing. More importantly, they manage the compliance infrastructure — PDMP integrations, e-prescribing systems, state-specific documentation requirements, physician collaborator networks for NPs in restricted states.

The DIY marketing alternative: Could you build this yourself? Theoretically, yes. Realistically, acquiring qualified psychiatric patients through SEO, Google Ads, or directories costs $200–500+ per patient when you factor in:

• Agency/consultant fees for campaign management
• Ad spend and testing ($15–40+ per click for mental health keywords)
• Staff time to handle and qualify leads
• No-show rates from cold leads
• 6–12 months before SEO generates meaningful patient flow
• Failed campaigns and wasted spend

Directory listings like Psychology Today or Zocdoc charge monthly subscriptions plus per-booking fees — and you’re competing with hundreds of other providers on the same page.

The platform model removes patient acquisition risk entirely: You pay only when a qualified patient books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad budget. For most providers — especially those starting out or scaling — this is the economically rational choice.

Staying Compliant: Practical Checklist

Here’s what you need to operate legally as a telehealth anxiety provider:

Before You Start:

• [ ] Valid medical or nursing license in every state where patients are located
• [ ] DEA registration (state-specific for controlled prescribing)
• [ ] State controlled substance license (where required: IL, FL, others)
• [ ] PDMP account registration in each practice state
• [ ] EPCS-compliant e-prescribing system with 2FA
• [ ] Malpractice insurance covering telehealth

For Each New Patient:

• [ ] Verify patient’s physical location (state compliance)
• [ ] Obtain informed consent for telehealth services (document in chart)
• [ ] Conduct appropriate evaluation via live audio-video (not text-only, not forms-only)
• [ ] Check state PDMP before prescribing any controlled substance
• [ ] Document encounter meeting same standards as in-person visit

Ongoing:

• [ ] Re-check PDMP per state requirements (every 30–90 days for ongoing controlled prescriptions)
• [ ] Use e-prescribing for all controlled medications (and all meds in CA/NY)
• [ ] Stay current on DEA policy changes (subscribe to DEA announcements)
• [ ] Review collaborative agreements annually (NPs in restricted states)
• [ ] Monitor state board guidance updates

The Bottom Line

Treating anxiety via telehealth is legally straightforward if you’re practicing within a single state’s regulations. The complexity comes from multi-state practice — which is also where the patient volume opportunity lies.

For psychiatrists: Your scope is unrestricted. Your challenge is administrative — licensing, PDMP compliance, e-prescribing systems.

For PMHNPs: Your scope varies by state. In full practice states (NY, IL, upcoming CA), you operate like psychiatrists. In restricted states (TX, FL, PA), you need physician collaboration infrastructure.

For both: Federal telehealth prescribing flexibility remains in effect through at least 2025, but monitor DEA announcements for potential changes. Build contingency plans for hybrid care models if in-person requirements return.

The providers succeeding in telehealth anxiety treatment aren’t necessarily the ones who understand every regulatory nuance — they’re the ones who partner with platforms that handle compliance infrastructure while they focus on clinical care.

Ready to treat anxiety patients via telehealth without the compliance headache? Klarity Health manages multi-state licensing support, PDMP integration, e-prescribing systems, and physician collaborator networks for NPs. You focus on clinical care; we handle the regulatory complexity. Join a network of psychiatrists and PMHNPs treating thousands of anxiety patients nationwide — with guaranteed ROI because you only pay when patients book.

Frequently Asked Questions

Can I prescribe benzodiazepines via telehealth to a new patient I’ve never seen in person?

Yes, under current federal rules (extended through December 2025 and likely beyond). The DEA’s COVID-era flexibilities allow prescribing Schedule II–V controlled substances via telemedicine without a prior in-person exam, provided you conduct an appropriate evaluation via live audio-video and comply with state laws. This applies to benzodiazepines (Schedule IV) commonly used for anxiety disorders.

Do I need a separate medical license for each state where my telehealth patients are located?

Yes. You must be licensed in the state where the patient is physically located during the telehealth encounter. Some states offer special telehealth licenses (like Florida’s Telehealth Provider Registration), and the Interstate Medical Licensure Compact can streamline licensing for physicians in member states, but you cannot practice across state lines without proper authorization.

What’s the difference between PMHNP practice in Texas vs. New York?

New York allows experienced PMHNPs (3,600+ hours) to practice independently without physician collaboration, including full prescribing authority. Texas requires PMHNPs to have a Prescriptive Authority Agreement with a physician for all practice and prohibits NPs from prescribing Schedule II controlled substances in outpatient settings. For anxiety treatment using benzodiazepines (Schedule IV), both states allow NP prescribing, but Texas requires physician supervision while New York (for experienced NPs) does not.

Do I have to check the state prescription monitoring database every time I refill a benzodiazepine prescription?

It depends on the state. New York requires a PDMP check for every Schedule II–IV prescription. Pennsylvania requires checking before each benzodiazepine or opioid prescription. Florida requires checking before initial prescription and at least every 90 days for ongoing therapy. California requires at least every 4 months. Check your specific state’s PDMP law — most states now mandate checks at least periodically for controlled substances.

Can I use audio-only (phone) telehealth to prescribe anxiety medications?

Federal law currently allows audio-only for buprenorphine prescribing (for opioid use disorder) but generally expects audio-visual for other controlled substances under the Ryan Haight exceptions. Some states like Illinois explicitly permit audio-only telehealth for mental health services, but best practice is to use video when possible for adequate mental status examination. Audio-only should be reserved for follow-ups or situations where video truly isn’t accessible, and you should document why video wasn’t used.

What happens if the DEA changes telehealth prescribing rules in 2026?

If the DEA reinstates in-person visit requirements for controlled substance prescribing, platforms and providers will need to adapt. Potential scenarios include: requiring an initial in-person exam within a certain timeframe, limiting telehealth-only prescribing to 30-day supplies, or implementing special DEA telemedicine registration. Many telehealth platforms are preparing hybrid models with partner clinics for in-person exams if needed. Monitor DEA announcements and have a plan to transition patients to compliant care models.

As a PMHNP in a restricted-practice state, can I still work for a telehealth platform?

Yes. Platforms operating in restricted-practice states (Texas, Florida, Pennsylvania) maintain physician collaborator networks specifically to enable PMHNP practice legally. The platform ensures you have the required supervisory or collaborative agreement in place before you see patients in those states. This is one of the key values of working with an established platform versus going solo — they handle the compliance infrastructure for multi-state practice.

Citations & Sources

The following sources were used to verify regulatory requirements, timelines, and compliance information in this guide:

1. DEA & HHS Extension of Telemedicine Prescribing Flexibilities – Drug Enforcement Administration, Press Release, November 15, 2024. ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ Available at: https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. §829(e)) – Federal statute establishing requirements for controlled substance prescribing via the Internet. Cornell Legal Information Institute. Available at: https://www.law.cornell.edu/uscode/text/21/829

3. Center for Connected Health Policy – State Telehealth Policies: Online Prescribing – Comprehensive state-by-state analysis of telehealth prescribing laws, updated January 9, 2026. Available at: https://www.cchpca.org/topic/online-prescribing/

4. Florida Statutes §456.47 (Telehealth Services) and §464.012 (APRN Practice & Prescribing) – Florida state laws governing telehealth practice and nurse practitioner controlled substance prescribing authority. Florida Legislature, 2025 edition. Available at: http://www.leg.state.fl.us/Statutes/

5. Texas Board of Nursing – APRN Prescriptive Authority FAQ – Official guidance on Schedule II prescribing limitations for Texas nurse practitioners, updated December 9, 2025. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html

Source:

• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=forward%20for%20telemedicine%2C%20DEA%20and,through%20the%20end%20of%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Note%20that%20the%20practice%20of,chapter%205%20of%20title%205
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,services%20within%20the%20applicable%20scope
• https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/#:~:text=Effective%20August%2027%2C%202013%2C%20most,to%20view%20dispensed%20controlled%20substance
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,care%20from%20a%20qualified%20hospice
• https://www.leg.state.fl.us/Statutes/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=893.03%20to%20a%207,formulary%20which%20it%20finds%20is
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Additionally%2C%20the%20rule%20shall%20state,addiction%20medicine%2C%20or%20palliative%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=The%20Attorney%20General%20may%20issue,application%20for%20such%20special%20registration%E2%80%94